Semperit Aktiengesellschaft Holding Overview
Semperit is a 200-year-old Austrian elastomer specialist that has completed a radical portfolio transformation. Between 2022 and mid-2024 it exited the volatile, Asia-centred medical-glove business (Sempermed) and bought RICO Group, a liquid-silicone-rubber (LSR) and high-precision mould maker. The group is now a pure-play industrial supplier with roughly €660–700m of revenue. It runs two divisions. Semperit Industrial Applications (SIA) is a cost-leadership series-production business in hydraulic and industrial hoses and sealing profiles. Semperit Engineered Applications (SEA) supplies customised conveyor belts, escalator handrails, cable-car rings, moulded parts and LSR components and tooling. Its competitive edge rests on scale assets, notably Europe's largest hose factory at Odry (CZ), in-house compounding, and niche leadership: the company claims No. 3 globally in hydraulic hoses and No. 2 in Europe in industrial hoses. Its earnings profile is highly operationally geared. After a weak 2025, operating EBITDA guidance for 2026 has been raised three times, to about €115m. A controlling shareholder (B&C, about 63.4%) and a shrinking free float shape the equity story.
Company's own description (AR 2025 / corporate boilerplate, paraphrased). Semperit develops, produces and sells high-quality elastomer products and applications for industrial customers in more than 100 countries through two divisions:
SIA: focuses on efficient large-scale production and cost leadership in hydraulic and industrial hoses and profiles.
SEA: makes escalator handrails, conveyor belts, cable-car rings and other engineered elastomer products, and includes the Rico Group (liquid silicone and mould making). Its emphasis is customised technical solutions.
Business model. Semperit is a B2B manufacturer of engineered and semi-engineered rubber and silicone products. Revenue is almost entirely product sales, plus a meaningful tooling/engineering component in LSR, where Rico designs and builds injection moulds and automation for customers and also produces series parts. The company discloses no subscription, licensing or service revenue as a separate stream; aftermarket and replacement demand (for example replacement hoses and conveyor-belt change-outs) is embedded in product sales. Its stated value-creation logic (FY2025 Earnings Presentation) rests on three ideas:
-
cost leverage from high utilisation of a large industrial base;
-
niche-market leadership, with the goal of ranking among the top 3 in each niche;
-
material and process technology combined with customer proximity.
Value-chain position. Semperit sits in the middle of the polymer value chain. It buys synthetic rubbers (butadiene-based SBR/NBR, EPDM), natural rubber, carbon black, steel wire, textiles and silicone raw materials. It compounds in-house at large mixing centres such as Bełchatów (PL, 75,000 t/yr capacity after a 2019 expansion), Odry, Wimpassing and Hückelhoven. It then converts compound into finished components sold to:
-
OEMs: hydraulic-equipment, construction, agricultural and mining machinery, escalator and elevator makers, rail, medical-device, food and baby-product makers;
-
distributors and hose-assembly specialists;
-
end users and EPC contractors, mainly mines, cement and steel plants for conveyor belts.
Customer types and end-markets.
Independent characterisation. Semperit is now a mid-cap, mid-cycle industrial components company. Roughly 40% of revenue is a scale-driven, commodity-adjacent hose and profile business with structurally high margins in good years (SIA EBITDA margin 28.0% in H1 2026). About 60% is an engineered/project business (SEA) whose margins are lower and more volatile, because it depends on mining capex, customer project timing and LSR tooling orders. The H1 2026 figures show the leverage clearly: an 11.1% revenue gain produced a more-than-doubling of EBITDA. The group's earnings quality therefore depends more on volume and utilisation than on pricing power.
Strategy
Stated strategy (FY2025 Earnings Presentation, 18 Mar 2026; paraphrased themes).
Ambition: more than €1bn in sales through profitable growth. The CEO describes this as a medium-term goal to be reached step by step.
Pillars: leading market positions in global niche markets (top-3 goal); a resilient business model (cost leverage at high utilisation, innovation as an extra growth driver); technological edge combined with customer proximity.
Strategic levers: Growth (focus on high-growth segments), Innovation (named the No. 1 growth driver), Performance (excellence and efficiency at all sites), People (diversity and open dialogue; Leadership Operating System with a "speak-up" culture).
Megatrends targeted: climate change, urbanisation/infrastructure, mobility, demographic shifts (healthcare and food), electrification.
Business-unit targets.
Initiatives in the last 24 months.
Medium-term financial targets and guidance history.
Products & Services
Semperit does not publish SKU-level pricing. All pricing is negotiated B2B and is "not publicly disclosed". Launch years are given only where disclosed.
SIA – Hoses (Semperit Hoses; formerly Semperflex)
| Product line | Description / capabilities | Target customer | Notes |
|---|---|---|---|
| Hydraulic hoses – wire braided | 1- and 2-wire braided high-pressure hoses for mobile and stationary hydraulics | Hydraulic OEMs, hose assemblers, distributors | Core volume product; Odry, plus Asian sites historically in Thailand and China |
| Hydraulic hoses – spiral | 4- and 6-spiral high and very-high pressure hoses for heavy construction and mining machinery | Construction/mining equipment OEMs | DH5 hall at Odry (+32m m/yr; total capacity almost 200m m/yr by full ramp-up) |
| Industrial hoses | Air, water, multipurpose, chemical, food, steam, oil & fuel hoses | Industrial distributors, plant operators | Company claims No. 2 in Europe in industrial hoses |
| Mandrel hoses | Mandrel-built, larger-diameter special hoses | Industrial specialty users | Moved to SEA (Form) on 1 Jan 2025 |
Strategic target (FY2025 Earnings Presentation): organic growth with a "hose-only" positioning and leading price/quality performance. The company claims No. 3 globally in hydraulic hoses (Odry press releases, 2022–2023).
SIA – Profiles (Semperit Profiles; formerly Semperseal/Semperform Profiles)
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| EPDM window and door seals | Extruded dense and cellular EPDM gaskets, mono to complex system solutions | Window/door fabricators, system houses | Deggendorf (DE) is the main profiles plant; historically described as Europe's largest maker of construction rubber gaskets (2017 release) |
| Façade and construction sealing | Custom profiles for curtain walls and façades | Façade builders | The project-oriented M+R Dichtungstechnik (Seligenstadt) was sold to Trelleborg on 1 Sep 2026 (about €7.4m external sales in 2025, about 20 staff) |
| Reclaimed EPDM profile (innovation) | Profiles containing 30% regenerated rubber from vulcanised EPDM scrap; up to 32% lower product carbon footprint vs standard | Sustainability-driven construction customers | Disclosed in FY2025 Earnings Presentation; concept under evaluation for post-industrial and post-consumer recycling |
Strategic target: global leader in EPDM sealing solutions with innovative and competitive solutions.
SEA – Form (Semperit Form)
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| Escalator handrails | Rubber/thermoplastic handrails for escalators and moving walks, new-build and replacement | Escalator OEMs, maintenance companies | Strong in Europe 2025–2026; China challenging |
| Cable-car rings | Elastomer rings and liners for ropeway sheaves | Ropeway manufacturers | Part of "mountain applications", a growth driver in 2025–2026 |
| Railway superstructure | Rail pads, elastic elements for track systems | Rail infrastructure operators and suppliers | Stable in 2025 despite project delays |
| Compression-moulded and engineered parts | Customised moulded rubber parts | Industrial OEMs | Co-developed solutions |
| Industrial sheeting | Rubber sheeting (historical Semperform line) | Industrial users | Current scope not separately disclosed |
| Mandrel hoses | See 5.1 | — | Since 2025 |
| RFID Rubber Tag (innovation) | Embeds a unique RFID identifier in rubber; designed for EU Digital Product Passport traceability | Industrial customers needing traceability | Prototype/customer-test stage (FY2025 Earnings Presentation) |
Strategic target: global platform for profitable niches through customised, co-developed solutions.
SEA – Belting (Sempertrans / Semperit Conveyor Belts)
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| Steel-cord conveyor belts | High-tension belts for long-distance and high-tonnage conveying | Mines (iron ore, copper, phosphate, nickel) | Bełchatów (PL) |
| Textile (fabric-ply) conveyor belts | EP-type multi-ply belts for general bulk handling | Cement, steel, quarries | Bełchatów (PL); Roha (IN) per Sempertrans 2023 booklet |
| Specialty belts (heat-, fire-, oil-resistant) | Application-specific covers | Steel, cement, underground mining | — |
| Transpipe | Pipe-conveyor belt solutions | Bulk handlers, EPCM contractors | Listed in Sempertrans reference booklet 2023 |
Strategic target: reliable solutions for demanding applications at full capacity utilisation.
SEA – LSR (RICO Group)
| Offering | Description | Target customer | Notes |
|---|---|---|---|
| LSR injection moulds and tooling | High-precision, complex moulds for liquid and solid silicone; single-, two- and multi-component | Medical, food & baby, automotive, consumer | Thalheim (AT) HQ; plant expansion completed post-acquisition |
| Series LSR components | Cleanroom series production of silicone parts | Medical/healthcare, baby care, mobility | Rico (AT), Silcoplast (CH), Simtec Silicone Parts (US) |
| Development services | Prototyping, component development consulting, automation | OEM engineering teams | Entire value chain from prototype to series |
| Example: silicone protective mask tooling (2025) | Modular mask (clinical ventilation, industrial protection, defence gas mask); combines thermoplastic and LSR via plasma treatment | Medical/defence OEMs | Flagship toolmaking project cited in the FY2025 presentation |
Strategic target: global growth in medical, sanitary and automotive, industrialising projects globally (including a planned US production expansion per the Q1 2025 investor presentation).
Exited portfolio (historical, for completeness)
| Former line | Status |
|---|---|
| Sempermed examination gloves (Malaysia), porcelain hand formers | Sold to Harps Global, closing 31 Aug 2023 |
| Surgical gloves (Wimpassing) and packaging (Sopron, HU) | Sold to Harps Global, closing 30 Jun 2024 (€7m) |
| Tyres | Sold 1985 |
Financial Narrative
Basis of preparation
The group's reported history has two breaks:
-
Medical was discontinued in 2022–2024. FY2021 headline figures include Medical; 2022 onward is "continuing operations".
-
Restatements. FY2023 was restated in the FY2024 report to exclude Surgical Operations (revenue €721.1m originally, €681.8m restated). FY2024 segments were restated for the mandrel-hose transfer.
Consequences for the tables:
-
FY2021 continuing-basis rows use Industrial Sector figures (revenue €556.1m, EBITDA €82.1m) from AR 2021 and the FY2025 Earnings Presentation LTM chart.
-
Group-level 2021 figures (EBITDA €361.8m, EAT €247.5m, EPS €11.99) include the glove boom and are shown separately.
-
Semperit reports by nature of expense, so gross profit is not reported. A proxy (revenue minus cost of materials, energy and purchased services) is given where disclosed.
Income statement
Notes:
-
FY2021 continuing revenue and EBITDA are Industrial Sector only (AR 2021). FY2022 continuing revenue (€779.8m) includes Surgical Operations contract manufacturing; the LTM chart basis (€734.0m) excludes it.
-
FY2023 continuing EAT is €24.4m on the restated basis (originally €24.9m); restated discontinued EAT is –€41.4m (originally –€41.9m).
-
FY2025 EBT is computed (EBIT €25.6m + financial result –€18.7m).
-
Diluted EPS equals basic; no dilutive instruments are disclosed.
-
FY2022 DPS = €1.50 base + €3.00 additional dividend paid after the Medical closing (Sept 2023).
-
2023 cost and expense lines are as presented in the FY2023 release; the FY2024 release used them as comparatives.
Sources: AR 2021 key figures; FY2021, FY2023, FY2024 and FY2025 press releases; FY2025 Earnings Presentation.
Margins and growth (%)
Revenue CAGR (computed, industrial LTM basis): FY2021–FY2025 +4.5% p.a. (€556.1m → €662.4m), inflated by the Rico acquisition (about €95m a year). FY2022–FY2025 –3.4% p.a. (€734.0m → €662.4m). Organic growth excluding Rico was clearly negative over 2022–2025.
Quarterly trajectory
Q2 2026 is computed as H1 2026 minus Q1 2026. Q3 2026 reported EBITDA is expected at about €27m (ad hoc, 12 Oct 2026); Q1–Q3 2026 at about €94m versus €52.0m a year earlier. Q3 2026 EBIT will carry an about €8m non-cash impairment.
Commentary.
-
The 2025 year reveals the group's operating leverage. Q1 2025 revenue fell 14% year on year while EBITDA fell 52%. In Q4 2025 a 5% revenue rise lifted EBITDA 31% (FY2025 Earnings Presentation).
-
The FY2025 EBITDA bridge from €84.9m shows: volume effects –€9.2m, price/mix –€5.0m, inventory change –€3.7m, personnel –€8.1m. Cost reduction contributed +€11.7m and consulting/warranties/other +€3.0m, leaving operating EBITDA of €83.6m before €4.1m oneERP costs.
-
Below EBITDA, depreciation rose to €49.5m (Rico and DH5). A €3.3m LSR customer-base impairment (€4.4m total impairments) and –€4.5m FX losses (weak USD) took 2025 EAT down to just €0.4m.
-
2026 is an inflection. H1 EBITDA was €66.6m (18.7% margin), EBIT €41.7m and EAT €28.6m (EPS €1.39).
Balance sheet
Notes:
-
Rounded component values (non-current assets, inventories, receivables, bank liabilities, Schuldschein, NCI, provisions) are read from the balance-sheet structure chart in the FY2025 Earnings Presentation.
-
A short-term versus long-term debt split and goodwill & intangibles are not disclosed in the sources reviewed; see the AR 2025 balance sheet.
-
An undrawn €100m credit line was available at YE2024 and YE2025.
Commentary.
-
2023 was the balance-sheet pivot. The Rico purchase (about €200m enterprise value implied by 12 × €16.5m, plus Thalheim capex compensation) and the €4.50/share dividend (about €92.6m, computed) turned a €54.2m net cash position into €115.2m net debt. Equity fell 17.9% and the equity ratio dropped from 61.5% to 45.3%.
-
Since then, deleveraging has been steady. Net debt went from €115.2m to €103.3m to €92.0m to €79.9m (H1 2026), helped by the €31m Schuldschein repayment in Q3 2025 from own resources.
Cash flow
Notes:
-
FY2021 FCF is group-level, including Medical (FY2021 release).
-
Semperit defines FCF as net cash flow adjusted for interest payments; it is not "operating cash flow minus capex". Operating cash flow is not disclosed in the sources reviewed.
-
Dividends paid in 2022–2024 are computed as DPS × about 20.57m shares. 2025 (€10.3m) is from the net-debt bridge in the FY2025 Earnings Presentation.
-
No buybacks are disclosed.
H1 2026: FCF €30.4m (H1 2025: €13.9m). Q1 2026: €13.1m.
FY2026 capex guidance: about €50m (about €35m maintenance, about €15m strategic growth).
Ratios
Current ratio and cash conversion cycle are not disclosed in the sources reviewed. Note that the 2025 financial result includes –€4.5m FX, so interest coverage on a pure interest basis is higher than shown. ROIC uses an assumed 25% tax rate and is not a company KPI.
Assessment. Returns are well below any reasonable cost of capital across 2023–2025: ROIC was about 4–5% and ROE near zero. This explains the share's discount to book value (the €20.20 per-share carrying amount cited by the board in May 2026) and gives context for the timing of B&C's €15 offer. On guided 2026 operating EBITDA of about €115m, and if depreciation stays near €50m, EBIT could roughly double versus 2025, lifting ROIC towards the high single digits. That is an analyst inference, not company guidance.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Business units | Products / content |
|---|---|---|
Semperit Industrial Applications (SIA) | Hoses; Profiles | Hydraulic hoses (spiral/braided), industrial hoses (air, water, chemicals, food, steam), EPDM window/door/façade profiles and gaskets |
Semperit Engineered Applications (SEA) | Form; Belting; LSR (Rico) | Escalator handrails, cable-car rings, railway superstructure components, compression-moulded parts, mandrel hoses; steel-cord and textile conveyor belts and Transpipe pipe conveyors; LSR components and high-precision moulds |
Corporate | Holding, oneERP project | Group functions; not a reporting segment |
Revenue by Segment
| Segment | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
SIA revenue – original definition (EUR Mn) | 450.2 | 330.8 | 293.5 | — |
SIA revenue – restated, mandrel hoses in SEA (EUR Mn) | — | — | 267.3 | 270.9 |
SEA revenue – original definition (EUR Mn) | 283.8 | 351.0 | 383.0 | — |
SEA revenue – restated (EUR Mn) | — | — | 409.3 | 391.5 |
of which Rico revenue in SEA (EUR Mn) | — | 37.2 | 94.6 | — |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Segment | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
SIA EBITDA – original (EUR Mn) | 88.0 | 46.9 | 52.2 | — |
SIA EBITDA – restated (EUR Mn) | — | — | 50.7 | 52.8 |
SEA EBITDA – original (EUR Mn) | 37.2 | 50.5 | 48.1 | — |
SEA EBITDA – restated (EUR Mn) | — | — | 49.6 | 42.5 |
Corporate EBITDA (EUR Mn) | — | -21.0 | -12.9 | -15.8 |
Results by Segment — SIA EBIT – original
| Segment | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
SIA EBIT – original (EUR Mn) | 67.9 | 29.7 | 31.3 | — |
SIA EBIT – restated (EUR Mn) | — | — | 31.8 | 34.7 |
SEA EBIT – original (EUR Mn) | 28.1 | 33.2 | 20.8 | — |
SEA EBIT – restated (EUR Mn) | — | — | 20.3 | 8.1 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
SIA EBITDA margin – original basis (%) | 19.5 | 14.2 | 17.8 | — |
SIA EBITDA margin – restated basis (%) | — | — | 19.0 | 19.5 |
SEA EBITDA margin – original basis (%) | 13.1 | 14.4 | 12.6 | — |
SEA EBITDA margin – restated basis (%) | — | — | 12.1 | 10.9 |
SIA EBIT margin – restated (%) | — | — | 11.9 | 12.8 |
SEA EBIT margin – restated (%) | — | — | 5.0 | 2.1 |
SIA share of revenue – restated (%) | — | — | 39.5 | 40.9 |
SEA share of revenue – restated (%) | — | — | 60.5 | 59.1 |
Revenue by Segment (%)
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
SIA (original basis 2023–24; restated 2025) (%) | -26.5 | -11.3 | 1.4 |
SEA (original basis 2023–24; restated 2025) (%) | 23.7 | 9.1 | -4.4 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment and Segment Margins & Growth (%)
| Metric | H1 2025 | H1 2026 |
|---|---|---|
SIA revenue (EUR Mn) | 133.6 | 149.7 |
SIA EBITDA (EUR Mn) | 24.2 | 41.9 |
SIA EBIT (EUR Mn) | 15.3 | 32.3 |
SIA EBITDA margin (%) | 18.1 | 28.0 |
SEA revenue (EUR Mn) | 186.9 | 206.2 |
SEA EBITDA (EUR Mn) | 14.7 | 32.4 |
SEA EBIT (EUR Mn) | -3.7 | 17.8 |
SEA EBITDA margin (%) | 7.9 | 15.7 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue – continuing/industrial basis (EUR Mn) | 556.1 | 779.8 | 681.8 | 676.6 | 662.4 |
Revenue – industrial businesses, LTM chart basis (EUR Mn) | 556.1 | 734.0 | 681.8 | 676.6 | 662.4 |
Revenue – as originally reported for year (EUR Mn) | — | 779.8 | 721.1 | 676.6 | 662.4 |
Cost of materials incl. energy and purchased services (EUR Mn) | — | — | 307.8 | 279.7 | 283.4 |
Gross profit proxy: revenue minus cost of materials (EUR Mn, computed) | — | — | 374.0 | 396.9 | 379.0 |
Personnel expenses (EUR Mn) | — | — | 206.5 | 218.8 | 222.0 |
Other operating expenses (EUR Mn) | — | — | 95.8 | 89.3 | 88.9 |
EBITDA – reported, continuing (EUR Mn) | 82.1 | 100.5 | 70.1 | 84.9 | 79.5 |
EBITDA – adjusted / operating (EUR Mn) | — | 95.8 | 80.0 | 86.3 | 83.6 |
EBITDA – group incl. Medical (EUR Mn) | 361.8 | — | — | — | — |
Depreciation and amortisation, regular (EUR Mn) | — | — | 36.5 | 47.5 | 49.5 |
EBIT – continuing (EUR Mn) | — | 62.1 | 34.0 | 35.0 | 25.6 |
Financial result (EUR Mn) | — | — | -8.7 | -13.4 | -18.7 |
Earnings before tax – continuing (EUR Mn) | — | — | 25.3 | 21.5 | 6.9 |
Income tax expense (EUR Mn) | — | — | 0.9 | 10.1 | 6.4 |
Earnings after tax – continuing operations (EUR Mn) | — | 38.4 | 24.4 | 11.4 | 0.4 |
Earnings after tax – discontinued operations (EUR Mn) | — | -44.0 | -41.4 | 0.1 | 0.0 |
Earnings after tax – total (EUR Mn) | 247.5 | -5.6 | -17.1 | 11.5 | 0.4 |
EPS basic (EUR) | 11.99 | -0.27 | -0.82 | 0.56 | 0.02 |
EPS diluted (EUR) | 11.99 | -0.27 | -0.82 | 0.56 | 0.02 |
Dividend per share for the fiscal year (EUR) | 1.50 | 4.50 | 0.50 | 0.50 | 0.00 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin proxy (%, computed) | — | — | 54.9 | 58.7 | 57.2 |
EBITDA margin – reported, continuing (%) | 14.8 | 12.9 | 10.3 | 12.5 | 12.0 |
Operating / adjusted EBITDA margin (%) | — | 12.3 | 11.7 | 12.8 | 12.6 |
EBIT margin (%) | — | 8.0 | 5.0 | 5.2 | 3.9 |
Net margin – continuing EAT / revenue (%, computed) | — | 4.9 | 3.6 | 1.7 | 0.1 |
Revenue growth, LTM industrial basis (%, computed) | — | 32.0 | -7.1 | -0.8 | -2.1 |
Income Statement and Margin Analysis (%)
| Metric | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue (EUR Mn) | 176.0 | 169.5 | 161.1 | 170.0 | 151.7 | 168.8 | 162.9 | 179.0 | 163.7 | 192.2 |
EBITDA (EUR Mn) | 23.0 | 24.4 | 16.6 | 21.0 | 11.1 | 19.6 | 21.3 | 27.4 | 26.8 | 39.8 |
EBIT (EUR Mn) | 11.6 | 12.1 | 3.1 | 8.2 | -1.3 | 4.0 | 9.2 | 13.8 | 14.4 | 27.3 |
EBITDA margin (%) | 13.0 | 14.4 | 10.3 | 12.4 | 7.3 | 11.6 | 13.1 | 15.3 | 16.4 | 20.7 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Total assets (EUR Mn) | 842.9 | 937.9 | 912.9 | 857.1 |
Non-current assets (EUR Mn) | — | — | 604 | 575 |
Inventories (EUR Mn) | — | — | 86 | 83 |
Trade receivables (EUR Mn) | — | — | 74 | 71 |
Cash and cash equivalents (EUR Mn) | — | 112.7 | 126.0 | 94.8 |
Short-term time deposits (EUR Mn) | — | — | — | 7.5 |
Financial liabilities, gross (EUR Mn) | — | — | 234.1 | 194.4 |
Liabilities to banks (EUR Mn) | — | — | 179 | 182 |
Corporate Schuldschein loan (EUR Mn) | — | — | 38 | 7 |
Net financial debt; negative = net cash (EUR Mn) | -54.2 | 115.2 | 103.3 | 92.0 |
Equity (EUR Mn) | 518.2 | 425.3 | 430.9 | 415.7 |
Equity ratio (%) | 61.5 | 45.3 | 47.2 | 48.5 |
Liabilities from redeemable non-controlling interests (EUR Mn) | — | — | 16 | 16 |
Provisions incl. social capital (EUR Mn) | — | — | 53 | 49 |
Trade working capital (% of LTM revenue) | — | — | 15.4 | 15.0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Analysis
| Item | Value |
|---|---|
Total assets | €900.0m |
Equity | €445.8m |
Equity ratio | 49.5% |
Net financial debt | €79.9m |
Liquidity reserves | €106.5m |
Net debt/EBITDA | 0.7x |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Free cash flow before sale of companies (EUR Mn) | 241.2 | -2.8 | 26.3 | 45.8 | 37.0 |
Free cash flow incl. sale of companies (EUR Mn) | — | -2.8 | 111.5 | 52.4 | 37.0 |
Capex – cash payouts incl. growth projects (EUR Mn) | — | — | — | 64.6 | 34.7 |
Additions to tangible and intangible assets (EUR Mn) | — | — | — | 62.4 | 31.6 |
of which growth capex (DH5 etc.) (EUR Mn) | — | — | — | — | 8.3 |
Dividends paid (EUR Mn) | — | 30.9 | 92.6 | 10.3 | 10.3 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
ROE – total EAT / average equity (%, computed) | — | -3.6 | 2.7 | 0.1 |
ROA – total EAT / average total assets (%, computed) | — | -1.9 | 1.2 | 0.0 |
ROIC – EBIT×(1–25%) / (equity + net debt) (%, analyst computation) | — | 4.7 | 4.9 | 3.8 |
Net financial debt / EBITDA (x) | -0.5 | 1.6 | 1.2 | 1.2 |
Gross financial debt / equity (x, computed) | — | — | 0.54 | 0.47 |
Net debt / equity (x, computed) | -0.10 | 0.27 | 0.24 | 0.22 |
Interest coverage – EBIT / abs. financial result (x, computed) | — | 3.9 | 2.6 | 1.4 |
Asset turnover – revenue / average total assets (x, computed) | — | 0.77 | 0.73 | 0.75 |
Equity ratio (%) | 61.5 | 45.3 | 47.2 | 48.5 |
Revenue by Region
| Division | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
SIA revenue (EUR Mn; 2023 original, 2024–25 restated) | 330.8 | 267.3 | 270.9 |
SEA revenue (EUR Mn; 2023 original, 2024–25 restated) | 351.0 | 409.3 | 391.5 |
Region Overview
| Region | Evidence | Direction |
|---|---|---|
Europe (core) | Odry, Wimpassing, Deggendorf and Bełchatów are the backbone. European handrails strong in 2025–2026. Profiles weak because of EU construction. Management cites the German infrastructure programme, EU defence spending and Ukraine reconstruction as medium-term drivers (FY2025 Earnings Presentation) | Stabilising; upside from infrastructure and defence |
North America | Rico acquisition explicitly expanded the US presence (Simtec); a US LSR production expansion is planned (Q1 2025 investor presentation); Newnan, GA hosts the Semperit Americas office. US tariff uncertainty hurt Belting in 2025 | Strategic growth region; tariff risk |
China / Asia | Form business in China described as challenging in 2025; hose and handrail sites in China and Thailand exist historically | Mixed / weak |
India | Conveyor-belt production at Roha (Sempertrans) | Mining/infrastructure exposure |
Global mining belts | Order intake and year-end backlog roughly flat in 2025 after a weak start | Cyclical |
Share Price & Returns
| Reference point | Price (EUR) | Source |
|---|---|---|
29 Oct 2024 | 11.5 | Craft (aggregator) |
Oct 2025 | Below 12.50 at the lows | Börse Express |
Start of 2026 (implied) | About 12.3 | Computed from YTD figures quoted in Aug 2026 |
Early Mar 2026 | 12.58 | Börse Express |
17 Jun 2026 | 14.85 | Goldesel |
16 Jul 2026 (52-week high at the time) | 15.65 | Börse Express |
52-week low (as of Aug 2026) | 11.46 | Börse Express |
13 Aug 2026 | 15.35 | Goldesel |
12 Oct 2026 | 19.10 | Goldesel |
Change by Horizon
| Horizon | Change |
|---|---|
YTD 2026 to 12 Oct (%) | 55 |
About 1 year to Oct 2026 (%) | 50 |
About 2 years to Oct 2026 (%) | 66 |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
Market capitalisation | About €393m | Price × shares |
Enterprise value | About €473m | Market cap + net financial debt €79.9m (30 Jun 2026); excludes leases, pensions and redeemable NCI |
EV / LTM EBITDA | About 4.1x | LTM EBITDA €115.4m (FY2025 €79.5m – H1 2025 €30.7m + H1 2026 €66.6m) |
EV / 2026e operating EBITDA | About 4.1x | Guidance about €115m |
EV / LTM sales | About 0.68x | LTM revenue €697.8m |
P/E (LTM) | About 9.8x | LTM EAT €40.2m, about €1.95/share; Der Aktionär shows a P/E of about 10 |
P/B | About 0.88x | Equity €445.8m (30 Jun 2026), about €21.67/share |
Offer-implied (€15.00) | About 5.4x EV/EBITDA FY26e | NuWays estimate before upgrades |
Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividend per share (EUR) | 1.50 | 4.50 | 0.50 | 0.50 | 0.00 |
Analyst Conclusions
Management guidance (12 Oct 2026).
Consensus growth expectations. A formal consensus is not publicly disclosed. The NuWays BUY rating and €21.5 target, set before the October upgrade, imply further upside expectations.
Bull case
-
Earnings power reset upward. Operating EBITDA guidance of about €115m is about 38% above 2025's €83.6m and approaches the old €120m medium-term target a year late. With the share at about 4x EV/EBITDA, even a modest multiple rerating is material.
-
DH5 and the cost base. SIA margins of 28% in H1 2026, plus DH5's ramp to 2028 and more than €10m of further annual cost cuts, provide structural margin support beyond the cycle.
-
Deleveraged balance sheet enables growth or returns. Net debt/EBITDA of 0.7x and about €106m of liquidity permit bolt-on M&A or a resumption of dividends. The stock trades below book value (P/B about 0.88x).
Bear case
-
Peak-ish quarter risk. Management itself warned the second half would be significantly more challenging. Raw-material inflation, project delays and short-term ordering could compress 2027 margins, much as 2025 followed 2024.
-
Structural growth deficit. Industrial revenue declined about 3.4% p.a. from 2022 to 2025. Profiles face a construction slump to at least 2027, and Belting and LSR are lumpy. The more-than-€1bn ambition lacks a timeline.
-
Governance and liquidity discount. B&C's 63.4% control, a free float of about 37%, the dividend suspension and a €15 offer below book value point to a persistent minority discount and potential further squeeze-type corporate actions.
Key catalysts and monitorables (next 12 months)
| Catalyst | Timing |
|---|---|
| Q1–Q3 2026 report: confirmation of Q3 about €27m and of the about €115m outlook; identity of held-for-sale assets | 12 Nov 2026 |
| FY2026 results and 2027 guidance; dividend decision for FY2026 | March 2027 |
| Raw-material and oil prices (Middle East); USD/EUR | Continuous |
| DH5 utilisation and SIA margin sustainability | Quarterly |
| SEA project flow (mining belts, LSR tooling); US LSR expansion decision | Quarterly |
| Any B&C corporate action (further purchases, delisting, squeeze-out) and free-float or index status | Ongoing |
| Bolt-on M&A or further divestitures; ContiTech sale outcome reshaping competition | 2026–2027 |
| oneERP milestones and costs | Through 2028 |
Analyst verdict
Semperit has completed one of the more decisive portfolio transformations among European mid-cap industrials. It shed a glove business that had swung from record profits to heavy losses, bought a technically differentiated LSR franchise, and rebuilt its cost base around a world-scale hose plant. The 2025 numbers looked unrewarding: revenue fell 2%, net profit was essentially zero, ROIC sat around 4% and the dividend was suspended. Yet they masked a business positioned for strong operating leverage. That leverage has now shown up. H1 2026 EBITDA more than doubled, SIA margins hit 28%, and guidance has been raised three times to about €115m of operating EBITDA, implying a margin near 16% on high-single-digit growth.
At about €19, the shares have already re-rated about 55% year to date and trade well above B&C's €15 offer. That vindicates the board's refusal to recommend the bid and minority holders' reluctance to tender. Even so, at about 4x EV/EBITDA, roughly 10x trailing earnings and below book value, the stock still prices in substantial scepticism. That scepticism has three grounds:
-
whether 2026 profitability is sustainable;
-
the structural growth gap of 2022–2025;
-
the governance overhang of a 63% controlling shareholder in an increasingly illiquid stock.
Our synthesis is constructive on fundamentals but disciplined on risk. If Q4 2026 and 2027 hold EBITDA above €100m while capex stays near €50m, free cash flow of €50–60m a year (an analyst inference) would rapidly de-gear the balance sheet and support either a dividend reinstatement or accretive bolt-ons. Each would argue for a valuation closer to analyst targets in the low €20s. The main swing factors are input costs, cyclical end-market demand and B&C's intentions. Investors should treat Semperit as a high-beta recovery and self-help story with a structural minority discount, not as a compounder. Upcoming confirmations (12 November results, 2027 guidance and the FY2026 dividend decision) are the critical tests.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Background | Age | Compensation |
|---|---|---|---|---|---|
Manfred Stanek | CEO / Chairman of the Executive Board | Board since 1 Mar 2025; CEO since 1 Apr 2025; mandate to 29 Feb 2028 | Executive Board member of Greiner AG (plastics/foam group); CEO of Greiner Packaging for six years; earlier roles at Votorantim Metais and Novelis; more than 25 years of international industry experience | About 55 (aggregator: Simply Wall St) | — |
Dr. Helmut Philipp Sorger | CFO | Since 1 Oct 2022 (register) | Responsible for finance, IR and risk | — | About €746k (aggregator; likely FY2024) |
Gerfried Eder | Chief Industrial Officer (CIO) | Since 1 Jul 2023; mandate extended early to mid-2029 | Former Managing Director of Semperflex (hoses); led the DH5/Odry expansion | — | About €931k (aggregator; likely FY2024) |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change |
|---|---|
| 2018 | Martin Füllenbach becomes CEO, succeeding Thomas Fahnemann's era (Fahnemann CEO with Frank Gumbinger as CFO from 2016) |
| 2021 | Karl Haider becomes CEO |
Oct 2022 | Sorger joins as CFO |
Jul 2023 | Eder joins as CIO |
26 Sep 2024 | Stanek appointed; Haider chose not to stand again, mandate expiring 31 Mar 2025 |
1 Apr 2025 | Stanek becomes CEO |
| 2025 | Eder's mandate extended to mid-2029 |
Jun 2026 | Stanek sold 3,200 shares (directors' dealing, per press coverage) |
Board of Directors
| Name | Role | Notes |
|---|---|---|
Thomas Cord Prinzhorn, MBA | Chair | Elected Apr 2023; Chair since the constituent meeting on 25 Apr 2023; re-elected 27 Apr 2026. Born 1972, Vienna; Babson MBA (magna cum laude, 2005); long-time executive of Prinzhorn Holding (paper/packaging) |
Dr. Stefan Fida | Deputy Chair (per 2019 release; acted as interim Chair Dec 2022–Apr 2023) | Long-serving member |
Univ.-Prof. Dr. Marion Weissenberger-Eibl | Member | — |
Dipl.-Wirtschaftsing. Claus Möhlenkamp | Member | Re-elected Apr 2023 until the AGM deciding on FY2026 discharge |
Dr. Klaus Erkes | Member | Re-elected Apr 2023 until the AGM deciding on FY2026 discharge |
Ing. Markus Stocker | Member (register entry 3 Feb 2026) | — |
Major Shareholders
| Holder | Stake | Source |
|---|---|---|
B&C Holding Österreich GmbH (B&C Group, Vienna; MD Patrick Lackenbucher) | About 63.4% after settlement (26 Jun 2026); 1,022,192 shares acquired at €15.00 in the offer | Offer result, 18 Jun 2026 (EVI); press coverage |
B&C stake before the offer | 58.48% per several reports (one research note cites 57.3%; discrepancy noted). The offer document targeted up to 8,542,034 shares (41.52%) | Offer documents |
Free float | About 36.6% (computed) | — |
Insider ownership | Not material; CEO sold 3,200 shares in June 2026 | Press |
Competitive Landscape
Competitors by Segment
| Business | Key competitors |
|---|---|
Hydraulic and industrial hoses (SIA) | Parker Hannifin; Danfoss Power Solutions (ex-Eaton Hydraulics); Gates Industrial; Manuli Hydraulics; Alfagomma; ContiTech (Continental); Bridgestone; Yokohama; Chinese and Indian producers |
Profiles (SIA) | Trelleborg; Hutchinson; Deventer; regional EPDM extruders |
Conveyor belts (SEA) | ContiTech; Fenner Dunlop (Michelin); Bridgestone; Yokohama; Chinese producers |
Handrails and ropeway rings (SEA) | EHC Global; ContiTech; captive OEM supply |
LSR components and tooling (SEA) | Trelleborg Medical Solutions; Freudenberg Medical; Datwyler; independent LSR moulders |
Peer Comparison FY2025
| Company | FY | Revenue | Growth | Margin metric | R&D intensity |
|---|---|---|---|---|---|
Semperit | 2025 | €662.4m | –2.1% | EBITDA 12.0% (operating 12.6%); EBIT 3.9% | — |
Trelleborg | 2025 | SEK 34,329m | Flat (organic +1%) | EBITA 18.3% (excl. items affecting comparability) | About SEK 1bn R&D (secondary source) |
Gates Industrial | 2025 | $3,443.2m | +1.0% (core +0.7%) | Adjusted EBITDA 22.4% | — |
ContiTech (Continental) | 2025 | €6,005m | –6.0% | Adjusted EBIT 5.3%; reported EBIT –€556m (restructuring) | — |
“—” = not publicly disclosed.



